We found no significant differences in platelet function in patients
with severe HA in prophylactic treatment before and after FVIII
infusion. After FVIII administration, patients presented fewer
endothelial microvesicles, indicating that the treatment does not
increase one of the possible thrombotic risk markers of these patients.